OTCMKTS:OPSSF Opsens (OPSSF) Stock Price, News & Analysis $2.14 +0.01 (+0.64%) As of 12/13/2023 Add Compare Share Share Stock Analysis Stock Analysis About Opsens Stock (OTCMKTS:OPSSF) Get Opsens alerts:Sign Up Key Stats Today's Range$2.12▼$2.1450-Day Range$2.14▼$2.1452-Week Range$0.97▼$2.14Volume36,000 shsAverage Volume44,497 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Opsens Inc. was a Canadian medical technology company headquartered in Quebec City, Quebec. The company developed and commercialized fiber-optic sensing solutions, with a primary focus on devices used in interventional cardiology and structural heart procedures. Its principal products included the OptoWire pressure guidewire, designed to help physicians measure coronary artery pressure and assess the physiological significance of arterial blockages, and the SavvyWire, a specialized device intended to support transcatheter aortic valve replacement procedures. Opsens’ technology was designed to provide pressure measurements in challenging clinical environments while supporting minimally invasive treatments. Founded in 2003, Opsens served the international medical-device market through regulatory approvals, commercial operations, and distribution relationships in North America, Europe, and other global regions. Haemonetics Corporation completed its acquisition of Opsens in 2023, after which Opsens became part of Haemonetics’ medical-device business. The company’s securities may therefore represent a historical listing rather than an independently operating public company.AI Generated. May Contain Errors. Read More Receive OPSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPSSF Stock News HeadlinesOpsens (OTCMKTS:OPSSF) Share Price Breaks Below Two Hundred Day Moving Average - Time to Sell?October 10 at 3:01 AM | americanbankingnews.comOpsens (OTCMKTS:OPSSF) Shares Cross Below Two Hundred Day Moving Average - Time to Sell?October 2, 2026 | americanbankingnews.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.October 11 at 1:00 AM | Banyan Hill Publishing (Ad)Opsens 4Q Loss Narrows, Revenue Tops ViewsNovember 22, 2023 | marketwatch.comOPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERSNovember 2, 2023 | finance.yahoo.comOPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPEOctober 23, 2023 | finance.yahoo.comOpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023October 17, 2023 | finance.yahoo.comOpsens' (TSE:OPS) investors will be pleased with their impressive 150% return over the last three yearsOctober 5, 2023 | finance.yahoo.comSee More Headlines OPSSF Stock Analysis - Frequently Asked Questions How have OPSSF shares performed this year? Opsens' stock was trading at $2.1389 at the start of the year. Since then, OPSSF stock has increased by 0.0% and is now trading at $2.1389. How were Opsens' earnings last quarter? Opsens Inc. (OTCMKTS:OPSSF) issued its quarterly earnings results on Tuesday, January, 21st. The company reported ($0.01) EPS for the quarter. How do I buy shares of Opsens? Shares of OPSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings1/21/2014Today10/11/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:OPSSF CIKN/A Webopsens.com Phone(418) 781-0333FaxN/AEmployees293Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:OPSSF) was last updated on 10/11/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opsens Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opsens With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
